Driving Value from Tax: Cash Incentives Available to Texas Life Sciences Companies
11:00 am – 12:00 pm
September 8, 2022
Join us to learn about Federal and State incentives available for companies in the life sciences industry.
11:00 am – 12:00 pm
September 8, 2022
Join us to learn about Federal and State incentives available for companies in the life sciences industry.
5:30 pm – 9:00 pm
September 8, 2022
The BioMedSA Award for Innovation in Healthcare and Bioscience celebrates local and national innovators in the healthcare and bioscience industry, including patient care, education, research and development, leadership, public policy and medical technology.
In 2022, the Innovation Award will be presented at a formal dinner in San Antonio, where healthcare and bioscience industry leaders can come together to celebrate healthcare innovation. The dinner will highlight and contribute to the collaborative spirit of the life science industry in San Antonio. Old associations will be rekindled in person and new relationships formed as industry leaders interact during the social hour preceding the dinner and the networking time after the dinner.
12:00 pm – 1:00 pm
September 13, 2022
The fair offers employers a great opportunity to meet diverse undergraduate and graduate students from all majors, promote your open positions, and build your brand with UT Austin students.
12:00 pm – 1:00 pm
September 14, 2022
NASA’s Lessons Learned Program was designed to educate new generations of NASA engineers on mistakes of the past in order to prevent future accidents, a lesson that can be taken to heart across industries involving teamwork by highly specialized teams.
All day
September 21, 2022 – September 23, 2022
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
11:00 am – 12:00 pm
September 21, 2022
The fair offers employers a great opportunity to meet diverse undergraduate and graduate students from all majors, promote your open positions, and build your brand with UT Austin students.
All day
September 21, 2022 – September 23, 2022
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
10:00 am – 11:00 am
September 22, 2022
During this webinar, NAMSA’s Principal IVD Biostatistician will examine the benefits of including biostatistics early and often in a clinical trial, provide insight on how to prevent unnecessary delays and walk through two real-world case studies.
All day
September 21, 2022 – September 23, 2022
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
8:00 am – 9:00 am
September 30, 2022
Virtual worlds help bridge the gap until the next time you can see a person in real life. We’ll explore the moments that matter and and why this is so important. More information at tagaustin.org